ASH Secretary (2021-2025): Cynthia E. Dunbar, MD
Cynthia E. Dunbar, MD, is the chief of the Translational Stem Cell Biology Branch within the Intramural Research Program of the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH) in Bethesda, MD, and was recently elected to the National Academy of Medicine.
Dr. Dunbar has previously served as editor-in-chief of the ASH flagship journal Blood from 2008-2013 after serving as associate editor from 1998-2007. She also served as a faculty member for the ASH-European Hematology Association Translational Research Training in Hematology Program from 2011–2016 and was co-director in 2016. She has served on the ASH Nominating Committee, the Program Committee, and recently completed a term as an ASH councillor. Since early 2020, Dr. Dunbar has also been part of a small group of ASH volunteers who mobilized in response to the COVID-19 pandemic to develop a series of clinical FAQs to address the impact of COVID-19 on patients with blood diseases and to curate a collection of a variety of resources to assist hematologists in navigating the ongoing public health crisis.
Dr. Dunbar’s research spans from basic laboratory studies through clinical trials focused on hematopoiesis, natural killer cell biology, hematopoietic stem cell and CAR-T cell gene therapies, and the pathophysiology and treatment of congenital and acquired bone marrow failure syndromes. As a prior hematology fellowship program director, and a founding member of the NIH Equity Committee, Dr. Dunbar is committed to developing and supporting a diverse hematology workforce.